Options and strategies for hearing restoration in pediatric neurofibromatosis type 2

• Published in: Child's nervous system Vol. 36; no. 10; pp. 2481 - 2487
• Main Authors: Mahboubi, Hossein, Slattery, William H., Mehta, Gautam U., Lekovic, Gregory P.
• Format: Journal Article
• Language: English
• Published: Berlin/Heidelberg Springer Berlin Heidelberg 01.10.2020
• Subjects: Annual Issue Paper; Medicine; Medicine & Public Health; Neurosciences; Neurosurgery; Cochlear implant; Deafness; Neurofibromatosis type 2; Auditory brainstem implant; Vestibular schwannoma; Hearing loss
• ISSN: 0256-7040; 1433-0350
• DOI: 10.1007/s00381-020-04721-4

Purpose In this article, we will review the mechanisms and natural history of hearing loss in neurofibromatosis type 2 (NF2) and discuss the hearing outcomes with different rehabilitation options. Methods Review of the published literature. Results NF2 is a rare autosomal dominant syndrome characterized by vestibular schwannomas and other intracranial and spinal tumors. Bilateral vestibular schwannomas are the hallmark of the disease which occur in 90 to 95% of the patients. As a result, hearing loss will eventually occur in almost all NF2 patients. Deafness can occur from tumor progression or from treatment of vestibular schwannomas and is among the most debilitating aspects of NF2. A number of surgical and non-surgical rehabilitation options are available for these patients including cochlear and auditory brainstem implants. The audiologic outcomes with surgical rehabilitation options have been variable but most patients are able to achieve sound awareness and benefit from auditory cues in lip reading. Conclusion Early identification and treatment of NF2 patients can help in achieving better hearing outcomes in the pediatric population. An increasing number of NF2 patients are receiving open set word understanding with refinement in surgical techniques.